Legal & General Group PLC Kal Vista Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

$368 Billion
Q4 2024

A detailed history of Legal & General Group PLC transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 8,144 shares of KALV stock, worth $97,157. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,144

Previous 6,650 22.47%

Holding current value

$97,157

Previous $77,000 11.69%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$8.09 - $12.5 $12,086 - $18,675	1,494 Added 22.47%	8,144 $68,000
Q3 2024 Feb 28, 2025	SELL	$9.46 - $15.39 $14,133 - $22,992	-1,494 Reduced 18.34%	6,650 $77,000
Q3 2024 Nov 14, 2024	BUY	$9.46 - $15.39 $2,554 - $4,155	270 Added 4.23%	6,650 $77,000
Q2 2024 Aug 14, 2024	BUY	$10.35 - $12.49 $39,164 - $47,262	3,784 Added 145.76%	6,380 $75,000
Q4 2023 Feb 15, 2024	BUY	$7.58 - $12.25 $4,881 - $7,889	644 Added 32.99%	2,596 $31,000
Q3 2023 Nov 14, 2023	SELL	$8.95 - $11.35 $3,624 - $4,596	-405 Reduced 17.18%	1,952 $18,000
Q3 2022 Nov 14, 2022	BUY	$9.85 - $16.83 $2,994 - $5,116	304 Added 14.81%	2,357 $34,000
Q2 2022 Aug 22, 2022	SELL	$8.16 - $15.1 $5,875 - $10,872	-720 Reduced 25.96%	2,053 $20,000
Q4 2021 Feb 14, 2022	BUY	$12.36 - $18.28 $3,967 - $5,867	321 Added 13.09%	2,773 $37,000
Q2 2021 Aug 12, 2021	BUY	$23.12 - $29.91 $18,172 - $23,509	786 Added 47.18%	2,452 $59,000
Q1 2021 May 17, 2021	BUY	$14.69 - $42.57 $5,112 - $14,814	348 Added 26.4%	1,666 $43,000
Q3 2020 Nov 13, 2020	SELL	$9.83 - $13.99 $4,108 - $5,847	-418 Reduced 24.08%	1,318 $17,000
Q2 2020 Aug 14, 2020	SELL	$6.75 - $12.89 $2,450 - $4,679	-363 Reduced 17.29%	1,736 $21,000
Q1 2020 May 14, 2020	SELL	$5.8 - $18.56 $1,873 - $5,994	-323 Reduced 13.34%	2,099 $16,000
Q4 2019 Feb 13, 2020	BUY	$10.31 - $17.81 $4,928 - $8,513	478 Added 24.59%	2,422 $40,000
Q2 2019 Aug 14, 2019	BUY	$18.44 - $30.89 $35,847 - $60,050	1,944 New	1,944 $43,000

Others Institutions Holding KALV

# of Institutions

130

Shares Held

53.2M

Call Options Held

63.5K

Put Options Held

36.6K

View Full List

About KalVista Pharmaceuticals, Inc.

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $294M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

More about KALV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Kal Vista Pharmaceuticals, Inc. Transaction History